Comparisons of efficacy and safety in insulin glargine and lixisenatide (iGlarLixi) plus glulisine combination therapy with multiple daily injection therapy in Japanese patients with type 2 diabetes

ConclusionsiGlarLixi + insulin glulisine combination therapy is safe and equally efficacious as multiple daily injection therapy for glycemic control, while avoiding hypoglycemia risk and reducing the number of injections are required.

Source: Journal of Diabetes Investigation - September 22, 2021 Category: Endocrinology Authors: Yuji Kawaguchi, Shoko Miyamoto, Yuriko Hajika, Narumi Ashida, Koji Masumoto, Jun Sawa, Kenji Hamazaki, Yasuro Kumeda Tags: ORIGINAL ARTICLE Source Type: research